However, although a biological relationship between LDH levels, tumour hypoxia and angiogenesis has been indicated in pre-clinical and clinical studies, the role of pre-treatment LDH levels in patients receiving anti-VEGF therapy remains substantially unexplored. This evidence concerns the gene VEGFA and neoplasm.